$16.15
4.06% today
Nasdaq, Apr 01, 06:47 pm CET
ISIN
IL0011316309
Symbol
MDWD
Sector
Industry

MediWound Ltd. Stock price

$15.52
-1.08 6.51% 1M
-2.54 14.06% 6M
-2.28 12.81% YTD
+1.35 9.53% 1Y
+1.59 11.41% 3Y
+4.53 41.22% 5Y
-35.16 69.38% 10Y
Nasdaq, Closing price Mon, Mar 31 2025
-0.43 2.70%
ISIN
IL0011316309
Symbol
MDWD
Sector
Industry

Key metrics

Market capitalization $174.63m
Enterprise Value $138.40m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 6.84
P/S ratio (TTM) P/S ratio 8.64
P/B ratio (TTM) P/B ratio 5.38
Revenue growth (TTM) Revenue growth 8.22%
Revenue (TTM) Revenue $20.22m
EBIT (operating result TTM) EBIT $-19.38m
Free Cash Flow (TTM) Free Cash Flow $-17.40m
Cash position $43.16m
EPS (TTM) EPS $-3.07
P/E forward negative
P/S forward 7.17
EV/Sales forward 5.68
Short interest 9.82%
Show more

Is MediWound Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

MediWound Ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a MediWound Ltd. forecast:

5x Buy
100%

Analyst Opinions

5 Analysts have issued a MediWound Ltd. forecast:

Buy
100%

Financial data from MediWound Ltd.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
20 20
8% 8%
100%
- Direct Costs 18 18
16% 16%
87%
2.63 2.63
27% 27%
13%
- Selling and Administrative Expenses 12 12
13% 13%
58%
- Research and Development Expense 8.88 8.88
19% 19%
44%
-18 -18
26% 26%
-89%
- Depreciation and Amortization 1.48 1.48
14% 14%
7%
EBIT (Operating Income) EBIT -19 -19
25% 25%
-96%
Net Profit -30 -30
350% 350%
-149%

In millions USD.

Don't miss a Thing! We will send you all news about MediWound Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MediWound Ltd. Stock News

Neutral
Seeking Alpha
13 days ago
MediWound Ltd. (NASDAQ:MDWD ) Q4 2024 Results Conference Call March 19, 2025 8:30 AM ET Company Participants Dan Ferry - IR, LifeSci Advisors Ofer Gonen - Chief Executive Officer Hani Luxenburg - Chief Financial Officer Barry Wolfenson - Executive Vice President, Strategy & Corporate Development Conference Call Participants Josh Jennings - Cowen Francois Brisebois - Oppenheimer RK - H.C.
Neutral
GlobeNewsWire
13 days ago
Initiated VALUE, a global Phase III pivotal trial of EscharEx® for venous leg ulcers Expanded strategic research collaborations with industry leaders, now including Kerecis $20 million in revenue for 2024; $24 million projected for 2025; $44 million in cash as of Year-End 2024 Conference call today, March 19 at 8:30am Eastern Time YAVNE, Israel, March 19, 2025 (GLOBE NEWSWIRE) -- MediWound Ltd....
Neutral
GlobeNewsWire
29 days ago
YAVNE, Israel, March 03, 2025 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2024 on Wednesday, March 19, 2025.
More MediWound Ltd. News

Company Profile

MediWound Ltd. is a biopharmaceutical company engaging in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product is NexoBrid. The company was founded by Lior Rosenberg and Marian Gorecki in 2001 and is headquartered in Yavne, Israel.

Head office Israel
CEO Ofer Gonen
Employees 111
Founded 2000
Website www.mediwound.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today